Citigroup raised the target price of Broadcom from $205.00 to $220.00.The S&P 500 index fell, and the Nasdaq 100 index rose to 0.6%.Bank of America Securities lowered the target price of Thermo Fisher Scientific Shier Technology from $675.00 to $660.00.
London cocoa futures rose more than 4% to 8516 pounds a ton. New york cocoa futures rose more than 4% to $11,296 a ton.Brazilian President Lula posted a video on social media for the first time after undergoing head surgery.London cocoa futures rose more than 4% to 8516 pounds a ton. New york cocoa futures rose more than 4% to $11,296 a ton.
The latest research results support Harvard's discovery that Novo Nordisk diet drug Ozempic is related to rare visual loss, and the large-scale test results show that Novo Nordisk diet drug Ozempic is related to rare visual loss, which supports the research results given by Harvard University earlier this year. Obese patients who use Ozempic are more than twice as likely to be diagnosed with NAION. NAION occurs when the blood flow decreases and damages the optic nerve. The risk of eye conditions is still low; Patients should pay attention. Novo Nordisk Denmark's share price once fell more than 3.3%.Anteris Technologies Global Corp. (AVR)' s U.S. IPO opened flat on the first day, at $6. This medical equipment supplier aims to improve the quality of life of patients with aortic stenosis.Funds continue to enter the market through the channel. The net subscription of stock ETFs exceeded 36.5 billion in the month. Since December, funds have continued to enter the market through stock ETFs (transactional open index funds). The data shows that as of December 13, the net subscription share of stock ETFs in the month reached 36.543 billion. From the perspective of specific capital flow, broad-based ETFs attract gold strongly, and many CSI A 500 ETFs and CSI 300ETF are actively subscribed by investors. In addition, dividend ETFs are also net subscribed by investors. (Securities Daily)
Strategy guide 12-14
Strategy guide
12-14
Strategy guide
12-14
Strategy guide
12-14